Retailers Deploy Dual Strategies of Price Cuts and Premiumization to Navigate KShaped Consumer Economy
Enhanced Games Steroid Olympics Backed by Trump Jr Thiel Set for Las Vegas Debut
Merlin Labs MRLN Attracts Market Scrutiny Amid Speculative Interest
Asia Pacific Real Estate Investment Surges 19 in Q1 India Emerges as Key Logistics and Data Centre Hub Savills Report
Sothebys Thwarts Attempt to Sell Counterfeit Ancient Artifacts Fraud Case Highlights Due Diligence in Art Market
Fluid Plumbing Electrical Air Conditioning Expands Residential Air Conditioning Services in Central Coast and Newcastle
KR Q1 2026 Earnings EPS Beat Fails to Inspire Shares Slip
CCIF Q1 2026 Earnings EPS of 009 Misses Estimates by 317
OKUR Q1 2026 Earnings WiderthanExpected Loss Reflects RD Investment
USBC Q1 2025 Earnings Narrowing Loss Exceeds Expectations
Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges
NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43
SoundHound AI Warrant SOUNW Declines 459 Support and Resistance Levels in Focus
Dermata Therapeutics DRMA Stages Modest Recovery Support Holds Above 128
Almonty Industries ALM Holds Near Support as Price Declines Fractionally
Brighthouse Financial Preferred Shares BHFAM Dip Slightly as Stock Hovers Near Key Support
Gladstone Investment Corporation Notes GAINZ Edge Higher With Modest Gain
Ryde Group Ltd RYDE Faces Modest Decline as Shares Test Key Support Zone
Diamondback Energy FANG Holds Steady Near Key Resistance as Energy Sector Shows Mixed Signals
Brookfield Renewable Partners Edges Higher as Renewable Sector Shows Resilience
Forum Energy Technologies FET Slides 239 Amid Sector Weakness Key Support Levels in Focus
KTech Solutions KMRK Holds Steady at 202 Amid Key Technical Levels
Reviva Pharmaceuticals Holdings Inc RVPH Holds Steady at 041 as Key Levels Define Trading Range
Marvell Technology Shares Dip Despite Strong AI Demand and Upbeat Growth Forecast
PHIO Q1 2026 Earnings EPS Misses Estimates Amid Continued Clinical Trials Focus
Voya Infrastructure Industrials and Materials Fund IDE Faces Selling Pressure as Shares Slide Over 1